Acquired
Novo Nordisk (Ozempic)
David Rosenthal
So regardless, the next year, 2015, is a record year. Total company revenues for Novo Nordisk hit $16 billion, which is incredible for a pure play diabetes and now diabetes and relatedly obesity pharma company. But the stock flatlines almost.
0
💬
0
Comments
Log in to comment.
There are no comments yet.